Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.
about
Ocular itch associated with allergic conjunctivitis: latest evidence and clinical managementComparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles.Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitisEfficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial.Antihistamines in late-phase clinical development for allergic disease.Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model.Recognition of allergic conjunctivitis in patients with allergic rhinitis.Epithelial cells in ocular allergy.Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge modelA review of the use of olopatadine in allergic conjunctivitis.Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.Investigation of the antiallergic activity of olopatadine on rhinitis induced by intranasal instillation of antigen in sensitized rats using thermography.Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops.Histamine H1 receptor-stimulated interleukin 8 and granulocyte macrophage colony-stimulating factor production by bronchial epithelial cells requires extracellular signal-regulated kinase signaling via protein kinase C.Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models.Management of vernal keratoconjunctivitis.Pharmacology, clinical efficacy and safety of olopatadine hydrochloride.Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells.A multicenter, double-blind, randomized, noninferiority comparison of 14 days' treatment with oral olopatadine 10 mg or cetirizine 10 mg in Chinese adults with cutaneous pruritus.Histamine-induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts.Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice.Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice.Clinical implications of mast cell involvement in allergic conjunctivitis.
P2860
Q26771818-5C34FFE3-F0CA-411F-B18E-0C5BDE7D2BC4Q33253499-91AC3C83-8FD6-421E-93E6-DFAF5AC2FB64Q33803658-61C5273D-1FA5-41B8-BB85-BC4FD71E9CE8Q34402432-212DC90B-4204-4AB6-BF2F-96C5A8C7D8EBQ34519151-3A80CFE6-BB3A-4E0D-AADA-272E5B34DF1AQ34708156-A1F332C9-60EB-435E-9CA8-78B5B57C0324Q34714641-6EC94CFA-1063-41C0-B3B6-ADC49DA8B7D7Q35147318-1578C3F9-7863-4687-A7FA-95F0A4A5359EQ36072416-C0CF5C3E-C1AD-456E-8C64-4701C0C198A6Q36104875-A97B117A-4033-48D6-B8CD-EBA5087EE0B9Q37716013-4452A4D6-F91A-4730-865C-ECB07ECF75BBQ38907362-6ED02D95-5B5F-42F5-8AB7-19795BC27A88Q39956528-A59656C2-96BD-4DFC-B5FF-5E6C089A327FQ40313696-1AB5AB1D-392B-4BF3-B328-38CFAADD55FAQ41813382-88B9B153-F41F-4C0A-BA17-0B0CA68A2F6AQ42138353-1AB1A5AF-61F1-47CC-8EEA-71E19B1A0116Q42745061-81AC73E4-E313-4507-941A-4CAF16EFFF35Q43061719-248F3398-EACB-4E55-BBCF-58B1F3FD4905Q43230761-AADC4E72-13D2-4816-9215-84DF847C757DQ43875672-CAD30FAA-CBDA-4399-AB62-A954F0035C54Q44329478-FA10B696-A7B1-4685-BDD2-9626351DA670Q45192136-3408635F-9D91-4EEA-9D61-17AB8216D3DBQ46533710-9B0701B7-DB1F-4629-ADE0-AC34BFB30B67Q48361100-11A70035-7BE7-479F-89AF-C8358F2D683F
P2860
Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@ast
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@en
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@nl
type
label
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@ast
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@en
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@nl
prefLabel
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@ast
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@en
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@nl
P2093
P1433
P1476
Inhibition of histamine-induce ...... onses by ocular allergy drugs.
@en
P2093
P304
P356
10.1001/ARCHOPHT.117.5.643
P407
P577
1999-05-01T00:00:00Z